Norway· NO-ID_740C8E94-D6EB-43B8-965F-733057F4820B

Ferriprox

A deferiprone product containing deferiprone, registered in Norway by Chiesi Farmaceutici S.p.a.. The same ATC class is registered in 16 of our 19 countries.

ATC V03AC02

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedFerriproxATCV03AC02REGISTER NO.NO-ID_740C8E94-D6EB-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Deferiprone is registered in 16 of 19 countries.

Countries holding a registration under ATC V03AC02 (deferiprone), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 10 of them publish a price we can compare per daily dose

Deferiprone · ATC V03AC02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of deferiprone costs, country by country.

Normalised to the WHO defined daily dose (5.25 g), the median price runs from $22.61 in Switzerland to $8636.08 in Italy — a ×382 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Deferiprone · price per daily dose (5.25 g)

USD · FX 28 Sept 2026

  • IT Italy$8636.08
  • CH Switzerland$22.61
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Deferiprone
Manufacturer
Chiesi Farmaceutici S.p.a.
Country
Norway (NO)
ATC code
V03AC02
ATC class
Deferiprone
Defined daily dose
5.25 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • gtin
    7046264530719
  • no_merkevare_id
    ID_740C8E94-D6EB-43B8-965F-733057F4820B
  • no_varenummer
    453071
    50
    NOK 2446.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

315 interactions on record for deferiprone.

Graded by severity as the source publishes them — 266 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Deferiprone · interactions on record

315 records

  • 266 severe
  • 49 moderate

Most severe, free to view

  • FostamatinibB02BX09severe
  • ProcainamideC01BA02severe
  • TocainideC01BB03severe
  • PropylthiouracilH03BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Deferiprone in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All deferiprone products

Authorised across Europe · EMA

The same active substance is authorised in 10 EEA countries. Names it is sold under:

  • Cyprus · Deferiprone Sapiens
  • Denmark · Deferipron Orifarm
  • France · Deferiprone Arrow
  • United Kingdom (Northern Ireland) · Deferiprone Mercury Pharmaceuticals, Deferiprone Mercury Pharmaceuticals Ltd.
  • Greece · Befeprox
  • Iceland · Ferriprox
  • Italy · Deferiprone Doc
  • Liechtenstein · Ferriprox
  • Portugal · Befeprox, Deferriprona Generis
  • Sweden · Deferipron Evolan, Deferiprone Doc

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3b85832a-aa97-4146-9047-2dbc267cf7bd
GET /v1/drugs/3b85832a-aa97-4146-9047-2dbc267cf7bd?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett, filmdrasjert",
  "source": "fest",
  "status": "A",
  "atc_name": "Deferipron",
  "merkevare_id": "ID_740C8E94-D6EB-43B8-965F-733057F4820B",
  "name_form_strength": "Ferriprox tab 1000 mg",
  "prescription_group": "C"
}

See everything about deferiprone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.